| The origin of SARS-CoV-2, history, present and future status of coronaviruses | Murat KAPLAN | 1–10 |
| The problem of the modern age: Covid-19 | Oya BULUT, Irmak DİK, Hatice Pelin ASLIM, Rüveyde GÜLBAHÇE | 11–16 |
| Transmission and replication dynamics of SARS CoV-2 | Mehmet Özkan TİMURKAN, Hakan AYDIN | 17–22 |
| Genomic organization of SARS-CoV-2 | Fırat DOĞAN, Ali Rıza BABAOĞLU, Gülizar ACAR KIRMIZI, Seval Bilge DAĞALP | 23–29 |
| Diagnostic approaches for COVID-19 | İlke Karayel HACIOĞLU | 30–40 |
| Molecular and epidemiological aspects of SARS CoV-2 | Cüneyt TAMER, Emre ÖZAN, Bahadır MÜFTÜOĞLU | 41–49 |
| Bioinformatics‐aided identification of SARS CoV-2 (COVID-19) | Mehmet Özkan TİMURKAN, Hakan AYDIN | 50–58 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): pathogenesis and virus-host interactions | Hasbi Sait SALTIK, Kamil ATLI, Mehmet KALE | 59–64 |
| Current knowledge on immunopathology and immunology of COVID-19 disease | Dilek AZKUR, Ahmet Kursat AZKUR | 65–75 |
| The mysterious of SARS and MERS vaccines, new approaches to a Coronavirus vaccine | Atilla ŞİMŞEK, Oğuzhan AVCI | 76–90 |
| Current clinical trials and vaccine development strategies COVID-19 infection and how to manage the risk of future outbreaks (prevention, control, and treatment) | Bahattin Taylan KOÇ | 91–98 |
| Animal coronaviruses, interspecies transmission and zoonotic potential | Fırat DOĞAN, Ali Rıza BABAOĞLU, Seval Bilge DAĞALP, İlker Şahinkesen, Enes Arda ARSLAN | 99–105 |
| Coronavirus infection in cats | Mahmut OK, Mutlu SEVİNÇ, Tuğçe Manolya BAŞ | 106–117 |
| Hava koşullarının ve küresel ısınmanın COVID-19 salgını üzerindeki etkisi | Hasbi Sait SALTIK, Kamil ATLI, Yakup YILDIRIM |